Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 5
1998 4
1999 3
2000 2
2004 1
2009 1
2010 3
2013 1
2014 6
2015 7
2016 9
2017 9
2018 10
2019 9
2020 13
2021 23
2022 26
2023 22
2024 40
2025 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Disaster preparedness among nurses: a systematic review of literature.
Labrague LJ, Hammad K, Gloe DS, McEnroe-Petitte DM, Fronda DC, Obeidat AA, Leocadio MC, Cayaban AR, Mirafuentes EC. Labrague LJ, et al. Among authors: obeidat aa. Int Nurs Rev. 2018 Mar;65(1):41-53. doi: 10.1111/inr.12369. Epub 2017 Mar 14. Int Nurs Rev. 2018. PMID: 28295314
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Disconnection.
Obeidat A. Obeidat A. Perm J. 2016 Summer;20(3):15-165. doi: 10.7812/TPP/15-165. Epub 2016 Jun 17. Perm J. 2016. PMID: 27352419 Free PMC article. No abstract available.
203 results